Safety, Tolerability, and Pharmacokinetics of SHC014748M in Patients With Indolent B-Cell Hematologic Malignancies

Clinical trial NCT03588598 · UNKNOWN

Trial details

NCT number: NCT03588598
Sponsor: Nanjing Sanhome Pharmaceutical, Co., Ltd.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Chronic Lymphocytic Leukemia (CLL)Small Lymphocytic Lymphoma (SLL)B-Cell Non-Hodgkin Lymphomas(NHL)

Start date: 2018-09-07
Primary completion: 2019-07-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.